The precise mechanisms by which reactive gliosis is established in the APOE4 AD brain is unknown, but a key question that remains is whether this gliosis is a driver of the disease, accounting for the earlier onset and worse prognosis APOE4 carriers face, or a by‐product of the exacerbated amyloid and tau pathology. The gene discussed is APOE; the disease is Alzheimer disease.